Peptide
GHK-Cu
Also known as
Copper peptide · GHK copper · glycyl-L-histidyl-L-lysine copper · GHK-Cu copper tripeptide · copper tripeptide-1 (cosmetic INCI contexts) · Gly-His-Lys-Cu · copper tripeptide-1
Community talk. May contain inaccuracies. Not medical advice. Not a protocol. Not for human or animal use.
What it is
| Copper-binding peptide | A three-amino-acid peptide bound to copper, also called copper tripeptide-1. |
|---|---|
| Why people discuss it | People hope for smoother-looking skin, less noticeable fine lines, existing scars becoming less noticeable and fuller-looking hair. |
| Forms discussed | Skin and scalp products, and injections beneath the skin (SubQ). Results from one form do not show what to expect from another. |
Notes
A small peptide bound to copper. GHK links three amino acids: glycine, histidine and lysine. GHK-Cu is its copper complex; copper tripeptide-1 is a cosmetic name. Tissue-remodeling research and user reports explain its skin-repair reputation without establishing that injections reverse aging. Badenhorst et al. (2016): Effects of GHK-Cu on MMP and TIMP Expression, Collagen and Elastin Production, and Facial Wrinkle Parameters (Official context · Accessed 2026-09-30)
Smoother texture, fewer visible lines and a healthier-looking glow. An 11-week injection log described marked skin improvement and early sting that later eased. Other skincare and uncontrolled photographs limit the conclusion. GHK-Cu 11 weeks progress — jbizzle81 (Personal report · Accessed 2026-09-30)
Fuller-looking hair and better-looking scars. Hair reports describe thickness, shine or less shedding. Some users also use minoxidil, finasteride, needling or other peptides, making GHK-Cu's contribution difficult to separate. Reports of better-looking skin or less noticeable scars during injury stacks do not establish tendon repair. GHK-Cu 11 weeks progress — jbizzle81 (Personal report · Accessed 2026-09-30)
Serums, scalp products and injections are different exposures. Topical accounts concern complexion or scalp appearance. SubQ means injection beneath the skin. GLOW adds BPC-157 and TB-500 to GHK-Cu; KLOW also adds KPV. A blend result cannot identify one ingredient's effect. GHK-Cu Topical vs Injectable (My Personal Experience) (Community discussion · Accessed 2026-09-30)
Source context — Badenhorst et al. (2016): Effects of GHK-Cu on MMP and TIMP Expression, Collagen and Elastin Production, and Facial Wrinkle Parameters: Small commercial-formulation trial with industry funding and laboratory arm. Not standalone injection efficacy, long-term safety, human intact-complex kinetics or community serum optimization. 71-person study mentioned in introduction is prior work, not this trial.
Source context — GHK-Cu 11 weeks progress — jbizzle81: Linked pictures were not visually inspected. Account and products unverified. Author's expectation of hair changes around month four is not observed regrowth. Preparation/site instructions excluded.
Source context — GHK-Cu Topical vs Injectable (My Personal Experience): Self-reports with tretinoin, SNAP-8, tranexamic acid and other compounds; no head-to-head trial. PIP means post-injection pain. Vendor suggestions and mixing/needle instructions not reused.
What people notice
| Skin appearance | Some people report firmer, smoother or more even-looking skin. |
|---|---|
| Hair appearance | Some people report thicker-looking hair or less shedding. Some also used minoxidil, finasteride or other treatments, so their reports cannot isolate GHK-Cu's contribution. |
| Less noticeable scars | Some people report that existing scars become less noticeable. |
| Immediate sensation | Some injection accounts describe sting or soreness; others report none. Sting does not demonstrate benefit. |
| Worse-looking skin | Dryness, breakouts, crepey appearance or deeper-looking lines are also reported. |
Notes
Skin firmness/texture: Firmer, smoother skin and fine-line talk over multi-week consistent use; photo reassess common at 8–12 weeks. [community]
Tone / glow: “Healthier glow,” even tone, or post-procedure recovery look before big structural change. [anecdote]
No visible improvement is also reported. One poster saw no skin/hair change after six weeks of 2 mg injections five days weekly. A reply reported no dramatic improvement after five months at 1–3 mg. Replies suggesting more time or zinc did not establish a cause. No results from GHK-Cu yet? (Community discussion · Accessed 2026-09-30)
Fuller-looking hair and better-looking scars. Hair reports describe thickness, shine or less shedding. Some users also use minoxidil, finasteride, needling or other peptides, making GHK-Cu's contribution difficult to separate. Reports of better-looking skin or less noticeable scars during injury stacks do not establish tendon repair. GHK-Cu 11 weeks progress — jbizzle81 (Personal report · Accessed 2026-09-30)
Soft-tissue adjacency: Injury stacks that add GHK-Cu often credit skin/scar quality more than tendon “feel.” [anecdote]
Injection sting can appear immediately; visible changes usually take longer. A GLOW user described first-week wasp-like pain, including much of the first day and night. Others reported no sting. This is local discomfort, not a marker of remodeling. I want to try GHK-CU but I'm hesitant (Community discussion · Accessed 2026-09-30)
Site reactions range from none to substantial pain or skin damage. Reports include redness, warmth, swelling, bruising, itch, ache and blue/purple marks. FDA flags possible immune reactions from aggregation/peptide impurities and limited human injection-safety data. Color, a purity claim or absence of sting cannot establish safety. A MESO-Rx poster reported skin injury with slow closure after 5 mg/day for ten days; the cause was unverified. I want to try GHK-CU but I'm hesitant (Community discussion · Accessed 2026-09-30) · FDA: Certain bulk drug substances that may present significant safety risks (Official context · Accessed 2026-09-30) · Looking to begin GHK-cu (Community discussion · Accessed 2026-09-30)
“Copper uglies” is a description, not proof of beneficial repair. The term covers dryness, breakouts, crepey appearance or deeper lines. One post describes worsening after two months at 2 mg/day; a reply describes later improvement. Older notes place onset around weeks 2–5 and easing around 4–6. None guarantees recovery or proves the proposed collagen-breakdown explanation. Copper Ugglies! About 2 months in with taking GHK 2mg daily (Community discussion · Accessed 2026-09-30) · GHK-Cu experience — r/Biohacking (Community discussion · Accessed 2026-09-30)
Source context — No results from GHK-Cu yet?: Self-reported nonresponse and delayed onset; no verified products or endpoints. Replies suggesting more time, zinc or product problems cannot explain the OP's outcome.
Source context — GHK-Cu 11 weeks progress — jbizzle81: Linked pictures were not visually inspected. Account and products unverified. Author's expectation of hair changes around month four is not observed regrowth. Preparation/site instructions excluded.
Source context — I want to try GHK-CU but I'm hesitant: Blend account does not establish a solo GHK-Cu reaction or mechanism. Purity and histamine claims unverified. Preparation, needle depth, injection site, massage and zinc dosing instructions excluded.
Source context — FDA: Certain bulk drug substances that may present significant safety risks: Route-specific risk context; not an incidence estimate, diagnosis of a reported reaction, efficacy assessment or proof that cosmetic use validates injection.
Source context — Looking to begin GHK-cu: Confounded self-reports and speculation about cause/product quality. Short-half-life statement supplies no assay, species or measured number. Product preparation and sourcing excluded. Used sparingly; no safety assurance accepted.
Source context — Copper Ugglies! About 2 months in with taking GHK 2mg daily: OP title does not independently confirm administration route or whether the three weeks refer specifically to time off; prose does not infer stopping. Reply's cause explanations and advice to persist are not validated.
Source context — GHK-Cu experience — r/Biohacking: Unverified self-reports. KLOW estimate is the poster's arithmetic, not authenticated component exposure. Ok-Figures does not specify frequency. No mechanism or lasting-damage diagnosis established.
Doses people talk about
| Solo SubQ charts | About 0.5–2 mg/day in community charts; higher amounts also circulate. These are reported totals, not safe limits. |
|---|---|
| One SubQ account | One user reports skin improvement by week four at 0.8 mg, worsening at 1 mg and improvement after stopping. How often they used it was not stated. |
| A no-result account | 2 mg, five days per week for six weeks, with no visible skin or hair improvement. This is a separate person from the 0.8 mg/1 mg account. |
| Topical concentration | 0.1–2% in older consumer notes. One commenter reports breakouts at 3% and better tolerance at 0.5%; label percentages can describe different things. |
| Topical frequency | Daily, twice daily and a few times weekly all appear; formulations differ. |
| Blend amounts | GLOW and KLOW milligrams include other peptides. Total blend milligrams are not GHK-Cu milligrams; component ratios and labels vary. |
Notes
Solo SubQ charts: about 0.5–2 mg total per day. Preserved community/clinic charts emphasize 1–2 mg/day, with 0.5–1 mg lower-amount talk, 2–3 mg intensive logs and occasional 4 mg/day claims. Other patterns are 1–2 mg two or three times weekly or morning/evening splits. These are reported totals, not safe ceilings. One freshly opened commenter reports 3 mg twice daily (6 mg/day), an outlying account rather than a ceiling. Copper and zinc balance while taking GHK-Cu — my results (Community discussion · Accessed 2026-09-30)
Individual reports: 800 mcg, 1 mg and higher weekday amounts. One user improved by week four at 800 mcg (0.8 mg), worsened at 1 mg and improved after stopping; frequency was unstated. Another logged 1.5, then 2, then 2.5 mg on administration days, five days on/two off. This is not an escalation recommendation. GHK-Cu experience — r/Biohacking (Community discussion · Accessed 2026-09-30) · GHK-Cu 11 weeks progress — jbizzle81 (Personal report · Accessed 2026-09-30)
Useful skin improvement can coexist with a reason to stop. The 800-mcg user improved, worsened at 1 mg and improved after stopping. The questioner clarified KLOW use, estimating 2.5 mg GHK-Cu five times weekly. Solo and blend accounts cannot establish the same cause. GHK-Cu experience — r/Biohacking (Community discussion · Accessed 2026-09-30)
No visible improvement is also reported. One poster saw no skin/hair change after six weeks of 2 mg injections five days weekly. A reply reported no dramatic improvement after five months at 1–3 mg. Replies suggesting more time or zinc did not establish a cause. No results from GHK-Cu yet? (Community discussion · Accessed 2026-09-30)
Topical reports: 0.1–2% in older consumer notes; actual accounts disagree. A commenter reported breakouts at 3% and better tolerance at 0.5%. Another preferred daily SubQ to a 2% topical. LongeCity questions seller claims for 2%; laboratory concentrations cannot establish an ideal finished serum. GHK-CU Topical — concentration and tolerance discussion (Personal report · Accessed 2026-09-30) · GHK-Cu Topical vs Injectable (My Personal Experience) (Community discussion · Accessed 2026-09-30) · GHK-CU Topical dosage/concentration (Community opinion · Accessed 2026-09-30)
More concentrated is not a settled definition of better. Posts disagree over 1%, 3% and higher hair percentages. A reported breakout at 3% contrasts with claims it is optimal. Stock-solution or total-peptide percentages may differ from actual GHK-Cu concentration; no optimal percentage is established. GHK-CU Topical — concentration and tolerance discussion (Personal report · Accessed 2026-09-30) · GHK-cu topical serum percentage (Community opinion · Accessed 2026-09-30)
Topical frequency: once or twice daily, or intermittent use. Preserved accounts include every-other-night or two or three times weekly use. A PurseForum serum user applied it a couple times weekly and was unsure it helped. Vehicles and percentages of total peptide mixtures differ. Let's talk GHK-Cu (Community discussion · Accessed 2026-09-30)
GLOW 5:1:1 and KLOW 5:1:1:1 are component ratios. Preserved GLOW 50/10/10 mg GHK-Cu/BPC-157/TB-500 means about 2.33 mg total blend contains 1.67/0.33/0.33 mg respectively. KLOW adds 10 mg KPV for 80 mg total. Labels vary; blend milligrams differ from GHK-Cu milligrams.
Source context — Copper and zinc balance while taking GHK-Cu — my results: OP body and old author's lab values unavailable today. This ledger entry supports visible replies only. Old GLOW/lab account retained separately through frozen profile locator; replies are not human PK or copper-safety evidence.
Source context — GHK-Cu experience — r/Biohacking: Unverified self-reports. KLOW estimate is the poster's arithmetic, not authenticated component exposure. Ok-Figures does not specify frequency. No mechanism or lasting-damage diagnosis established.
Source context — GHK-Cu 11 weeks progress — jbizzle81: Linked pictures were not visually inspected. Account and products unverified. Author's expectation of hair changes around month four is not observed regrowth. Preparation/site instructions excluded.
Source context — No results from GHK-Cu yet?: Self-reported nonresponse and delayed onset; no verified products or endpoints. Replies suggesting more time, zinc or product problems cannot explain the OP's outcome.
Source context — GHK-CU Topical — concentration and tolerance discussion: Homemade formulation claims and concentration unverified. Claimed 3% saturation limit not accepted as a biological fact. Search dated July 8 versus relative displayed timestamps disagree; no exact publication date asserted.
Source context — GHK-Cu Topical vs Injectable (My Personal Experience): Self-reports with tretinoin, SNAP-8, tranexamic acid and other compounds; no head-to-head trial. PIP means post-injection pain. Vendor suggestions and mixing/needle instructions not reused.
Source context — GHK-CU Topical dosage/concentration: A question and laboratory-to-serum comparison, not a first-person outcome or validated topical amount. Linked studies not used as topical-dose evidence. DIY arithmetic not reproduced.
Source context — GHK-cu topical serum percentage: Unverified opinions and unsupported optimal-percentage assertions. Specific commercial formula composition is not verified by these commenters; prose treats it as a label-interpretation dispute. DIY recipes not reproduced.
Source context — Let's talk GHK-Cu: No verified chemistry, objective outcome or specified serum concentration. Forum carries affiliate disclosure. Linked before/after pictures not visually inspected. No purchase or soreness-reduction recipe reproduced.
Half-life, onset & duration
| Visible skin changes | Some logs describe changes around 4–6 weeks; others describe changes after several months. Photos are often compared at 8–12 weeks. |
|---|---|
| Hair changes | 12–16 weeks or longer is discussed as an expectation, not a guaranteed regrowth window. |
| Half-life | No reliable human value is identified here. Online estimates conflict; see Notes. |
| Duration after stopping | Uncertain. There is no dependable single-use benefit window or lasting-after-stopping interval; local sting can outlast the injection. |
Notes
Skin: around four to six weeks in some logs; months or no change in others. The 800-mcg account improved by week four; a mixed topical/injection account noticed changes around week six. Other replies describe month-four onset or none after five months. Older accounts include softness at 1–2 weeks and photos at 8–12 weeks. GHK-Cu experience — r/Biohacking (Community discussion · Accessed 2026-09-30) · GHK-Cu Topical vs Injectable (My Personal Experience) (Community discussion · Accessed 2026-09-30) · No results from GHK-Cu yet? (Community discussion · Accessed 2026-09-30)
Hair: 12–16 weeks or longer is discussed. The 11-week poster felt fuller, shinier hair but expected more changes around month four. Scalp discussions extend to 3–6 or 6–12 months. Expectations are not guaranteed regrowth. GHK-Cu 11 weeks progress — jbizzle81 (Personal report · Accessed 2026-09-30)
About 30 minutes, 105 minutes and 2–4 hours all circulate. These conflicting GHK-related figures persist in the community record. Their study, measured substance, species and route remain unresolved. They cannot establish a measured human GHK-Cu value; this review found no suitable human clearance study.
No dependable benefit duration for a single application or injection. Logs concern repeated use. One commenter felt smoothness faded during a month off; an adverse poster described three weeks without improvement. Benefit after stopping remains uncertain. Copper and zinc balance while taking GHK-Cu — my results (Community discussion · Accessed 2026-09-30) · Copper Ugglies! About 2 months in with taking GHK 2mg daily (Community discussion · Accessed 2026-09-30)
Local discomfort can outlast the injection. The GLOW account's first 1–2 days included day-and-night stinging, later less frequent. Symptom duration differs from half-life and course length. I want to try GHK-CU but I'm hesitant (Community discussion · Accessed 2026-09-30)
Source context — GHK-Cu experience — r/Biohacking: Unverified self-reports. KLOW estimate is the poster's arithmetic, not authenticated component exposure. Ok-Figures does not specify frequency. No mechanism or lasting-damage diagnosis established.
Source context — GHK-Cu Topical vs Injectable (My Personal Experience): Self-reports with tretinoin, SNAP-8, tranexamic acid and other compounds; no head-to-head trial. PIP means post-injection pain. Vendor suggestions and mixing/needle instructions not reused.
Source context — No results from GHK-Cu yet?: Self-reported nonresponse and delayed onset; no verified products or endpoints. Replies suggesting more time, zinc or product problems cannot explain the OP's outcome.
Source context — GHK-Cu 11 weeks progress — jbizzle81: Linked pictures were not visually inspected. Account and products unverified. Author's expectation of hair changes around month four is not observed regrowth. Preparation/site instructions excluded.
Source context — Copper and zinc balance while taking GHK-Cu — my results: OP body and old author's lab values unavailable today. This ledger entry supports visible replies only. Old GLOW/lab account retained separately through frozen profile locator; replies are not human PK or copper-safety evidence.
Source context — Copper Ugglies! About 2 months in with taking GHK 2mg daily: OP title does not independently confirm administration route or whether the three weeks refer specifically to time off; prose does not infer stopping. Reply's cause explanations and advice to persist are not validated.
Source context — I want to try GHK-CU but I'm hesitant: Blend account does not establish a solo GHK-Cu reaction or mechanism. Purity and histamine claims unverified. Preparation, needle depth, injection site, massage and zinc dosing instructions excluded.
Cycles people discuss
| Solo injection blocks | 4–8 weeks on and 2–4 weeks off is one chart pattern. Alternatives include 30 days on/14–30 off or eight weeks on/eight off. |
|---|---|
| Weekday pattern | Five days on/two off appears in an 11-week log; it does not establish an optimal calendar. |
| Topical use | Ongoing skincare, intermittent use and pauses for irritation all appear. |
| Reasons for breaks | Cost, needles, irritation and copper concerns are cited. No proven tolerance-reset schedule is established. |
Notes
Solo injection charts: 30 days on/14–30 days off, or 4–8-week blocks. Preserved alternatives are 4–8 weeks on/2–4 weeks off or eight weeks on/eight weeks off. Weekday use appears within 30–60 days. Cost, needles and copper concerns are reasons given; no proven tolerance-reset rule settles it.
Opening body lines 20–36: skin/hair impressions, three weeks at 1.5 mg, three at 2 mg, week seven onward at 2.5 mg, each five days on/two off; early sting and skincare context. GHK-Cu 11 weeks progress — jbizzle81 (Personal report · Accessed 2026-09-30)
Smoother texture, fewer visible lines and a healthier-looking glow. An 11-week injection log described marked skin improvement and early sting that later eased. Other skincare and uncontrolled photographs limit the conclusion. GHK-Cu 11 weeks progress — jbizzle81 (Personal report · Accessed 2026-09-30)
Continuous topical use and stopping for irritation coexist. Some keep skincare ongoing or pause for irritation. Others reject breaks or cycle injections. The inspected eight-week mixed-route account and 11-week weekday log describe courses without establishing an optimal calendar. GHK-Cu Topical vs Injectable (My Personal Experience) (Community discussion · Accessed 2026-09-30) · GHK-Cu 11 weeks progress — jbizzle81 (Personal report · Accessed 2026-09-30) · Copper Ugglies! About 2 months in with taking GHK 2mg daily (Community discussion · Accessed 2026-09-30)
Why cycle injectables at all: Cost, needle burden, copper-load caution, and thin chronic human SC data — not a proven “tolerance reset” law. [community]
Source context — GHK-Cu 11 weeks progress — jbizzle81: Linked pictures were not visually inspected. Account and products unverified. Author's expectation of hair changes around month four is not observed regrowth. Preparation/site instructions excluded.
Source context — GHK-Cu Topical vs Injectable (My Personal Experience): Self-reports with tretinoin, SNAP-8, tranexamic acid and other compounds; no head-to-head trial. PIP means post-injection pain. Vendor suggestions and mixing/needle instructions not reused.
Source context — Copper Ugglies! About 2 months in with taking GHK 2mg daily: OP title does not independently confirm administration route or whether the three weeks refer specifically to time off; prose does not infer stopping. Reply's cause explanations and advice to persist are not validated.
Stacks
| GLOW and KLOW | GLOW combines GHK-Cu, BPC-157 and TB-500; KLOW adds KPV. Premixes fix component ratios, and their outcomes cannot isolate one ingredient. |
|---|---|
| Skin and hair routines | Moisturizer, sunscreen, retinoids, minoxidil, finasteride and needling occur alongside it. Those routines can contribute to appearance changes too. |
| Zinc discussion | Some add zinc; others dispute a universal need. No standardized companion amount is established. |
Notes
Serums, scalp products and injections are different exposures. Topical accounts concern complexion or scalp appearance. SubQ means injection beneath the skin. GLOW adds BPC-157 and TB-500 to GHK-Cu; KLOW also adds KPV. A blend result cannot identify one ingredient's effect. GHK-Cu Topical vs Injectable (My Personal Experience) (Community discussion · Accessed 2026-09-30)
Premixes fix the component ratios and make individual effects harder to identify. Separate-vial talk includes BPC-157 250–500 mcg/day and TB-500 multi-milligram once or twice weekly schedules. Premixes lock them together; extra standalone GHK-Cu can confuse totals. Storage and color-change discussions do not authenticate contents.
Topical skin routine: GHK-Cu serum + moisturizer + SPF; rotate or time-separate strong AHA/BHA, high-strength L-ascorbic acid, and retinoids to reduce sting and inactivation fights. [community]
Hair stack confounds: Minoxidil, microneedling, finasteride/dutasteride, rosemary, other hair peptides (including AHK-Cu) — nearly impossible to isolate GHK-Cu credit. [community]
Skincare routines and photo conditions affect the comparison. Topical accounts describe cleansing/showering, serum then moisturizer after 1–5 minutes, and sunscreen; scalp accounts describe after-shampoo application and separate minoxidil timing. Other skincare and sleep can affect appearance, while different photo conditions make changes harder to judge.
Copper/zinc explanations remain contested. Some add zinc; others dispute a universal need. Copper, zinc, ceruloplasmin and liver tests appear in discussion, confounded by changing stacks and missing baselines. Headache/malaise are nonspecific reports. Pregnancy, lactation and cancer-history precautions reflect uncertainty around systemic research use. Copper and zinc balance while taking GHK-Cu — my results (Community discussion · Accessed 2026-09-30)
Zinc balance talk: Long/high injectable copper-peptide runs often pair with zinc supplementation discussion (copper–zinc antagonism lore) — not a standardized trial protocol. [community]
Source context — GHK-Cu Topical vs Injectable (My Personal Experience): Self-reports with tretinoin, SNAP-8, tranexamic acid and other compounds; no head-to-head trial. PIP means post-injection pain. Vendor suggestions and mixing/needle instructions not reused.
Source context — Copper and zinc balance while taking GHK-Cu — my results: OP body and old author's lab values unavailable today. This ledger entry supports visible replies only. Old GLOW/lab account retained separately through frozen profile locator; replies are not human PK or copper-safety evidence.
Watch for
| Skin irritation | Dryness, breakouts and worse-looking texture are reported. The term copper uglies does not prove beneficial repair or guarantee that worsening will resolve. |
|---|---|
| Injection reactions | Reports include sting, redness, swelling, bruising and pain; some describe substantial reactions or skin injury. |
| Injection safety | The saved FDA record flags possible immune reactions from aggregation or peptide impurities, with limited human injection-safety data. Color or absence of sting cannot establish safety. |
| Layering and needling | Acids, retinoids and freshly needled skin can complicate irritation. Ordinary serum use does not establish safety on broken skin. |
| Copper balance and medical context | Headache, malaise and copper–zinc concerns appear; symptoms alone cannot diagnose an imbalance. Systemic-use precautions in the record include pregnancy, lactation and cancer history. |
Notes
“Copper uglies” is a description, not proof of beneficial repair. The term covers dryness, breakouts, crepey appearance or deeper lines. One post describes worsening after two months at 2 mg/day; a reply describes later improvement. Older notes place onset around weeks 2–5 and easing around 4–6. None guarantees recovery or proves the proposed collagen-breakdown explanation. Copper Ugglies! About 2 months in with taking GHK 2mg daily (Community discussion · Accessed 2026-09-30) · GHK-Cu experience — r/Biohacking (Community discussion · Accessed 2026-09-30)
Site reactions range from none to substantial pain or skin damage. Reports include redness, warmth, swelling, bruising, itch, ache and blue/purple marks. FDA flags possible immune reactions from aggregation/peptide impurities and limited human injection-safety data. Color, a purity claim or absence of sting cannot establish safety. A MESO-Rx poster reported skin injury with slow closure after 5 mg/day for ten days; the cause was unverified. I want to try GHK-CU but I'm hesitant (Community discussion · Accessed 2026-09-30) · FDA: Certain bulk drug substances that may present significant safety risks (Official context · Accessed 2026-09-30) · Looking to begin GHK-cu (Community discussion · Accessed 2026-09-30)
Layering and freshly needled skin complicate irritation. Community debates involve acids, retinoids, strong vitamin C and benzoyl peroxide. Their effects can overlap with GHK-Cu. Ordinary serum strength is not validated for open skin channels; “tenfold absorption” lore cannot determine a safe amount.
Copper/zinc explanations remain contested. Some add zinc; others dispute a universal need. Copper, zinc, ceruloplasmin and liver tests appear in discussion, confounded by changing stacks and missing baselines. Headache/malaise are nonspecific reports. Pregnancy, lactation and cancer-history precautions reflect uncertainty around systemic research use. Copper and zinc balance while taking GHK-Cu — my results (Community discussion · Accessed 2026-09-30)
Source context — Copper Ugglies! About 2 months in with taking GHK 2mg daily: OP title does not independently confirm administration route or whether the three weeks refer specifically to time off; prose does not infer stopping. Reply's cause explanations and advice to persist are not validated.
Source context — GHK-Cu experience — r/Biohacking: Unverified self-reports. KLOW estimate is the poster's arithmetic, not authenticated component exposure. Ok-Figures does not specify frequency. No mechanism or lasting-damage diagnosis established.
Source context — I want to try GHK-CU but I'm hesitant: Blend account does not establish a solo GHK-Cu reaction or mechanism. Purity and histamine claims unverified. Preparation, needle depth, injection site, massage and zinc dosing instructions excluded.
Source context — FDA: Certain bulk drug substances that may present significant safety risks: Route-specific risk context; not an incidence estimate, diagnosis of a reported reaction, efficacy assessment or proof that cosmetic use validates injection.
Source context — Looking to begin GHK-cu: Confounded self-reports and speculation about cause/product quality. Short-half-life statement supplies no assay, species or measured number. Product preparation and sourcing excluded. Used sparingly; no safety assurance accepted.
Source context — Copper and zinc balance while taking GHK-Cu — my results: OP body and old author's lab values unavailable today. This ledger entry supports visible replies only. Old GLOW/lab account retained separately through frozen profile locator; replies are not human PK or copper-safety evidence.
Full notes
GHK-Cu is a copper-binding peptide discussed for smoother skin, less visible fine lines and existing scars, and fuller-looking hair. Skincare users apply it topically; peptide users also report injections, alone or in GLOW/KLOW blends. Experiences range from visible improvement to no change or worse-looking skin, and those forms cannot be treated as equivalent.
What GHK-Cu is
- A small peptide bound to copper. GHK links three amino acids: glycine, histidine and lysine. GHK-Cu is its copper complex; copper tripeptide-1 is a cosmetic name. Tissue-remodeling research and user reports explain its skin-repair reputation without establishing that injections reverse aging. Official context Community
- Serums, scalp products and injections are different exposures. Topical accounts concern complexion or scalp appearance. SubQ means injection beneath the skin. GLOW adds BPC-157 and TB-500 to GHK-Cu; KLOW also adds KPV. A blend result cannot identify one ingredient's effect. Reddit r/BiohackingU Community
Benefits people seek and report
- Smoother texture, fewer visible lines and a healthier-looking glow. An 11-week injection log described marked skin improvement and early sting that later eased. Other skincare and uncontrolled photographs limit the conclusion. Personal report
- Fuller-looking hair and better-looking scars. Hair reports describe thickness, shine or less shedding. Some users also use minoxidil, finasteride, needling or other peptides, making GHK-Cu's contribution difficult to separate. Reports of better-looking skin or less noticeable scars during injury stacks do not establish tendon repair. Personal report Community Community
- No visible improvement is also reported. One poster saw no skin/hair change after six weeks of 2 mg injections five days weekly. A reply reported no dramatic improvement after five months at 1–3 mg. Replies suggesting more time or zinc did not establish a cause. Reddit r/BiohackingU
Doses people discuss
Amounts below describe reports and circulated charts, not instructions. 1,000 mcg equals 1 mg.
- Solo SubQ charts: about 0.5–2 mg total per day. Preserved community/clinic charts emphasize 1–2 mg/day, with 0.5–1 mg lower-amount talk, 2–3 mg intensive logs and occasional 4 mg/day claims. Other patterns are 1–2 mg two or three times weekly or morning/evening splits. These are reported totals, not safe ceilings. One freshly opened commenter reports 3 mg twice daily (6 mg/day), an outlying account rather than a ceiling. Community Reddit r/Biohacking
- Individual reports: 800 mcg, 1 mg and higher weekday amounts. One user improved by week four at 800 mcg (0.8 mg), worsened at 1 mg and improved after stopping; frequency was unstated. Another logged 1.5, then 2, then 2.5 mg on administration days, five days on/two off. This is not an escalation recommendation. Reddit r/Biohacking Personal report
- Topical reports: 0.1–2% in older consumer notes; actual accounts disagree. A commenter reported breakouts at 3% and better tolerance at 0.5%. Another preferred daily SubQ to a 2% topical. LongeCity questions seller claims for 2%; laboratory concentrations cannot establish an ideal finished serum. Community Personal report Reddit r/BiohackingU LongeCity
- Topical frequency: once or twice daily, or intermittent use. Preserved accounts include every-other-night or two or three times weekly use. A PurseForum serum user applied it a couple times weekly and was unsure it helped. Vehicles and percentages of total peptide mixtures differ. Community PurseForum
- GLOW 5:1:1 and KLOW 5:1:1:1 are component ratios. Preserved GLOW 50/10/10 mg GHK-Cu/BPC-157/TB-500 means about 2.33 mg total blend contains 1.67/0.33/0.33 mg respectively. KLOW adds 10 mg KPV for 80 mg total. Labels vary; blend milligrams differ from GHK-Cu milligrams. Community
Half-life
- About 30 minutes, 105 minutes and 2–4 hours all circulate. These conflicting GHK-related figures persist in the community record. Their study, measured substance, species and route remain unresolved. They cannot establish a measured human GHK-Cu value; this review found no suitable human clearance study. Community
- A short-half-life argument does not settle frequency. MESO-Rx uses presumed short clearance to argue for repeated injections; others use weekdays only. Those preferences do not measure intact peptide–copper clearance, and weeks of skin change cannot validate a blood half-life. MESO-Rx Community
Onset: when people notice a change
- Injection sting can appear immediately; visible changes usually take longer. A GLOW user described first-week wasp-like pain, including much of the first day and night. Others reported no sting. This is local discomfort, not a marker of remodeling. Reddit r/Peptidesource
- Skin: around four to six weeks in some logs; months or no change in others. The 800-mcg account improved by week four; a mixed topical/injection account noticed changes around week six. Other replies describe month-four onset or none after five months. Older accounts include softness at 1–2 weeks and photos at 8–12 weeks. Reddit r/Biohacking Reddit r/BiohackingU Reddit r/BiohackingU Community
- Hair: 12–16 weeks or longer is discussed. The 11-week poster felt fuller, shinier hair but expected more changes around month four. Scalp discussions extend to 3–6 or 6–12 months. Expectations are not guaranteed regrowth. Personal report Community
Duration: how long changes last
- No dependable benefit duration for a single application or injection. Logs concern repeated use. One commenter felt smoothness faded during a month off; an adverse poster described three weeks without improvement. Benefit after stopping remains uncertain. Reddit r/Biohacking Reddit r/PeptideForum
- Local discomfort can outlast the injection. The GLOW account's first 1–2 days included day-and-night stinging, later less frequent. Symptom duration differs from half-life and course length. Reddit r/Peptidesource
Cycles and breaks
- Solo injection charts: 30 days on/14–30 days off, or 4–8-week blocks. Preserved alternatives are 4–8 weeks on/2–4 weeks off or eight weeks on/eight weeks off. Weekday use appears within 30–60 days. Cost, needles and copper concerns are reasons given; no proven tolerance-reset rule settles it. Community
- GLOW: four weeks on/2–4 weeks off; KLOW: 6–12-week blocks. GLOW accounts also describe 6–8 or 8–12 weeks; KLOW breaks are multi-week. Short 10–14-day injury add-ons are thinner stack-guide claims. Premixes prevent independent component schedules. Community Community
- Continuous topical use and stopping for irritation coexist. Some keep skincare ongoing or pause for irritation. Others reject breaks or cycle injections. The inspected eight-week mixed-route account and 11-week weekday log describe courses without establishing an optimal calendar. Community Reddit r/BiohackingU Personal report Reddit r/PeptideForum
Good to know
- “Copper uglies” is a description, not proof of beneficial repair. The term covers dryness, breakouts, crepey appearance or deeper lines. One post describes worsening after two months at 2 mg/day; a reply describes later improvement. Older notes place onset around weeks 2–5 and easing around 4–6. None guarantees recovery or proves the proposed collagen-breakdown explanation. Reddit r/PeptideForum Reddit r/Biohacking
- Site reactions range from none to substantial pain or skin damage. Reports include redness, warmth, swelling, bruising, itch, ache and blue/purple marks. FDA flags possible immune reactions from aggregation/peptide impurities and limited human injection-safety data. Color, a purity claim or absence of sting cannot establish safety. A MESO-Rx poster reported skin injury with slow closure after 5 mg/day for ten days; the cause was unverified. Community Reddit r/Peptidesource Official context MESO-Rx
- Layering and freshly needled skin complicate irritation. Community debates involve acids, retinoids, strong vitamin C and benzoyl peroxide. Their effects can overlap with GHK-Cu. Ordinary serum strength is not validated for open skin channels; “tenfold absorption” lore cannot determine a safe amount. Community Community
- Copper/zinc explanations remain contested. Some add zinc; others dispute a universal need. Copper, zinc, ceruloplasmin and liver tests appear in discussion, confounded by changing stacks and missing baselines. Headache/malaise are nonspecific reports. Pregnancy, lactation and cancer-history precautions reflect uncertainty around systemic research use. Reddit r/Biohacking Community Community
From community discussion
- The preferred route differs between people. One author preferred topical results because injection pain was annoying; a reply preferred 1 mg/day SubQ and saw little from 2% topical. Opposing impressions cannot rank the routes. Reddit r/BiohackingU
- Useful skin improvement can coexist with a reason to stop. The 800-mcg user improved, worsened at 1 mg and improved after stopping. The questioner clarified KLOW use, estimating 2.5 mg GHK-Cu five times weekly. Solo and blend accounts cannot establish the same cause. Reddit r/Biohacking
- Changing stacks make copper/zinc tests hard to interpret. One archived account reports 1.5 mg during GLOW use six days weekly, worsening after two weeks, a two-week pause, then separate GHK-Cu four nights weekly. Component/total ambiguity, zinc changes, Wolverine co-use and no pre-use labs prevent causal interpretation. Community
- Skincare routines and photo conditions affect the comparison. Topical accounts describe cleansing/showering, serum then moisturizer after 1–5 minutes, and sunscreen; scalp accounts describe after-shampoo application and separate minoxidil timing. Other skincare and sleep can affect appearance, while different photo conditions make changes harder to judge. Community Community
- More concentrated is not a settled definition of better. Posts disagree over 1%, 3% and higher hair percentages. A reported breakout at 3% contrasts with claims it is optimal. Stock-solution or total-peptide percentages may differ from actual GHK-Cu concentration; no optimal percentage is established. Personal report Reddit r/Peptidesource
- Premixes fix the component ratios and make individual effects harder to identify. Separate-vial talk includes BPC-157 250–500 mcg/day and TB-500 multi-milligram once or twice weekly schedules. Premixes lock them together; extra standalone GHK-Cu can confuse totals. Storage and color-change discussions do not authenticate contents. Community Community Community
Supporting research and regulatory context
- Topical formulation research does not validate injection charts. Badenhorst's 2016 split-face study involved 40 women aged 40–65, eight weeks and a carrier-enhanced serum. Results are formulation-specific; Snowberry helped fund it. The cited older 71-person trial is not this study. Official context
- Non-injectable compounding review is distinct from drug approval. FDA's May 14, 2026 list returned non-injectable GHK-Cu to Category 1 and records withdrawal of the injectable nomination. It states intended consultation before February 2027 ends. Evaluation status is not approval. Official context
